Traditional and emerging applications of microspheres: A review

International Journal of PharmTech Research

Volumn 2, Issue 1, 2010, Pages 675-681

  Shanthi, C Nithya ^a   Gupta, Rakesh ^a   Mahato, Arun Kumar ^b  

^a Bharat Sewak Shiksha Samiti   (India)

^b JAIPUR NATIONAL UNIVERSITY   (India)

Author keywords

Traditional and emerging applications of microspheres

Indexed keywords

ASTATINE 211; CARBON 14; CERIUM 141; CHROMIUM 51; COBALT 57; HISTAMINE H3 RECEPTOR; INDIUM 111; LEAD 212; MICROSPHERE; PHOSPHORUS 32; RHENIUM 186; RHENIUM 188; STRONTIUM 85; SULFUR 35; TECHNETIUM 99M; YTTRIUM 90;

CONFOCAL MICROSCOPY; DIAGNOSTIC PROCEDURE; DNA SEQUENCE; DRUG DELIVERY SYSTEM; FLUORESCENCE; HIGH THROUGHPUT SCREENING; HUMAN; MOLECULAR BIOLOGY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77953469670     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Cleland, J.L., and Jones, A.J.S., Stable formulations of recombinant human growth hormone and interferon-ô for microencapsulation in biodegradable microspheres, Pharmaceut. Res, 1996, 13, 1464-1475.
2. Mehta, R.C., Jeyanthi.R., Calis.S., Thanoo.B.C., Burton.K.W., and DeLuca.P.P., Biodegradable microspheres as depot system for parenteral delivery of peptide drugs, J. Contr. Rel, 1994, 29, 375-384.
3. Mathiowitz, E., Jacob, J.S., Jong, Y.S., Carino, G.P., Chickering, D.E., Chaturvedi, P., Santos, C.A., Vijayaraghavan, K., Montgomery, S., Bassett, M., and Morrell, C, Biologically erodable microspheres as potential oral drug delivery systems, Nature, 1997 386, 410-414.
4. Papisov, M.I., Modeling in vivo transfer of long-circulating polymers (two classes of long circulating polymers and factors affecting their transfer in vivo), Adv. Drug Del, Rev, 1995, 16, 127-139.
5. Torchilin, V.P., and Trubetskoy, V.S., Which polymers can make nanoparticulate drug carriers long-circulating? Adv. Drug Del. Rev, 1995, 16, 141-155.
6. Gupta, P.K., Review article: Drug targeting in cancer chemotherapy: A clinical perspective, J. Pharm. Sci, 1990, 79, 949-962.
7. Roser, M., Fischer, D., and Kissel, T., Sufacemodified biodegradable albumin nano- and microspheres, Part II: Effect of surface charges on in vitro phagocytosis and biodistribution in rats, Eur. J. Pharm. Biopharm, 1998, 46, 255-263.
8. Hafeli, U.O., Magnetically modulated therapeutic systems, Int.J.Pharm, 2004, 277, 19-24.
9. Widder, K.J., Senyei, A.E., Ranney, D.F., Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents, Adv. Pharmacol. Chemother, 1979, 16, 213-271.
10. Gupta, P.K., Hung, C.T., Magnetically controlled targeted micro-carrier systems, Life Sci, 1989, 44, 175-186.
11. Häfeli, U., Schütt, W., Teller, J., Zborowski, M., Scientific and Clinical Applications of Magnetic Carriers, first ed. Plenum Press, New York, 1997.
12. Häfeli, U.O., Radioactive magnetic microspheres, In: Arshady, R. (Ed.), Microspheres, Microcapsules & Liposomes: Magneto- and Radio-Pharmaceuticals, vol. 3, Citus Books, London, Chapter 18, 2001, pp. 559-584.
13. Johnson, J., Kent, T., Koda, J., Peterson, C., Rudge, S., Tapolsky, G., The MTC technology: a platform technology for the site-specific delivery of pharmaceutical agents. Eur. Cells Mater. 2002, 3, 12-15.
14. Scherer, F., Anton, M., Schillinger, U., Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Therapy, 2002, 9, 102-109.
15. Chen, H., Langer, R., Magnetically-responsive polymerized liposomes as potential oral delivery vehicles, Pharm. Res, 1997, 14, 537-540.
16. Saini, S., Stark, D.D., Hahn, P.F., Wittenberg, J., Brady, T.J., Ferrucci, J.T., Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system, Radiology, 1987, 162, 211-216.
17. Molho, P., Verrier, P., Stieltjes, N., Schacher, J.M., Ounnoughene, N., Vassilieff, D., Menkes, C.J., and Sultan, Y, A retrospective study on chemical and radioactive synovectomy in severe haemophilia patients with recurrent haemarthrosis, Haemophilia, 1999, 5, 115-123.
18. Keys, H.M., Bundy, B.N., Stehman, F.B., Muderspach, L.I., Chafe, W.E., Suggs, C.L., Walker, J.L., and Gersell, D., Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma, The New England J of Medicine, 1999, 340, 1154-1161.
19. Rose, P.G., Bundy, B.N., Watkins, E.B., Thigpen, J.T., Deppe, G., Maiman, M.A., Clarke-Pearson, D.L, and Insalaco, S., Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer, The New England J of Medicine, 1999, 340, 1144-1153.
20. Heymann, M.A., Payne, B.D., Hoffman, J.I., and Rudolph, A.M, Blood flow measurements with radionuclide-labeled particles, Progress in Cardiovascular Diseases, 1977, 20, 55-79.
21. European Working Group on Clinical Analysis, Cytofluorometric methods for assessing absolute number of cell subsets in blood. Cytometry, Comm. Clin. Cytometry, 2000, 42: 327-346.
22. Storie, I., Sawle, A., Goodfellow, K., Whitby, L., Granger, V., Ward, R.Y., Peel, J., Smart, T., Reilly, J.T., Barnett, D., Perfect-Count: A novel approach for the single platform enumeration of absolute CD4+ Tlymphocytes. Cytometry Part B, (Clinical Cytometry), 2004,57B, 47-52.
23. Bangs, L.B, Microspheres for medical diagnostics: Specific tests and assays, In Arshady R (Ed.), Microspheres, microcapsules and liposomes, Citus Books, London, 1999, 71-96.
24. White, I.M., Hanumegowda, N.M., Fan, X., Subfemtomole detection of small molecules with microsphere sensors, Optic letters, 2005, 30, 3189-91.
25. Estapor Fluorescent microspheres, Merck, www.estapor.com.
26. Rosendaal, F.R., Venous thrombosis: a multicausal disease [Review], Lancet, 1999, 353, 1167-73.
27. Bauer, K.A., The thrombophilias: well-defined risk factors with uncertain therapeutic implications, Ann Intern Med, 2001, 135, 367-73.
28. Bertina, R.M., Factor V Leiden and other coagulation factor mutations affecting thrombotic risk, Clin Chem, 1997, 43, 1678-83.
29. Miletich, J.P., Thrombophilia as a multigenic disorder, Semin Thromb Hemost, 1998, 24, 13-20.
30. Heit, J.A., Venous thromboembolism epidemiology: Implications for prevention and management, Semin Thromb Hemost, 2002, 28, 3-13.
31. Ronaghi, M., Karamohamed, S., Pettersson, B., Uhlen, M., and Nyren, P, Real-time DNA sequencing using detection of pyrophosphate release, Analytical Biochemistry, 1996, 242, 84-89.
32. Ronaghi, M, Pyrosequencing sheds light on DNA sequencing, Genome Research, 2001, 11, 3-11.